Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Spicer

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|January 30, 2018
Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor TypesKristina M Ilieva, Anthony Cheung, Silvia Mele, et al.
Oncoimmunology|January 30, 2018
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)Ricarda M Hoffmann, Ben G T Coumbe, Debra H Josephs, et al.
Clinical and Translational Radiation Oncology|August 4, 2018
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumoursM T Dillon, Z Boylan, D Smith, et al.
Cancer Letters|February 23, 2017
Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cellsAstero Klampatsa, Daniela Y Achkova, David M Davies, et al.
Frontiers in Immunology|April 10, 2018
Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B CellsIsabel Correa, Kristina M Ilieva, Silvia Crescioli, et al.
Journal of Psychiatric Nursing and Mental Health Services|November 1, 1978
A descriptive study of the attitudes of psychiatrists toward the new role of the nurse therapistK R Davidson, K B Donovan, C S Gilman, et al.
Cancers|April 26, 2020
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing MelanomaRicarda M Hoffmann, Silvia Crescioli, Silvia Mele, et al.
Mabs|November 27, 2019
<i>In vivo</i> safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelIwan P Williams, Silvia Crescioli, Heng Sheng Sow, et al.
The Journal of Allergy and Clinical Immunology|January 24, 2018
Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncologySilvia Crescioli, Giulia Chiaruttini, Silvia Mele, et al.
Oncotarget|June 2, 2016
Targeting folate receptor alpha for cancer treatmentAnthony Cheung, Heather J Bax, Debra H Josephs, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|January 30, 2018
Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor TypesKristina M Ilieva, Anthony Cheung, Silvia Mele, et al.
Oncoimmunology|January 30, 2018
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)Ricarda M Hoffmann, Ben G T Coumbe, Debra H Josephs, et al.
Clinical and Translational Radiation Oncology|August 4, 2018
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumoursM T Dillon, Z Boylan, D Smith, et al.
Cancer Letters|February 23, 2017
Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cellsAstero Klampatsa, Daniela Y Achkova, David M Davies, et al.
Frontiers in Immunology|April 10, 2018
Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B CellsIsabel Correa, Kristina M Ilieva, Silvia Crescioli, et al.
Journal of Psychiatric Nursing and Mental Health Services|November 1, 1978
A descriptive study of the attitudes of psychiatrists toward the new role of the nurse therapistK R Davidson, K B Donovan, C S Gilman, et al.
Cancers|April 26, 2020
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing MelanomaRicarda M Hoffmann, Silvia Crescioli, Silvia Mele, et al.
Mabs|November 27, 2019
<i>In vivo</i> safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelIwan P Williams, Silvia Crescioli, Heng Sheng Sow, et al.
The Journal of Allergy and Clinical Immunology|January 24, 2018
Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncologySilvia Crescioli, Giulia Chiaruttini, Silvia Mele, et al.
Oncotarget|June 2, 2016
Targeting folate receptor alpha for cancer treatmentAnthony Cheung, Heather J Bax, Debra H Josephs, et al.
Pageof 8